Following the scoping workshop held on Thursday 10th July 2025 it was identified that ex-situ machine perfusion devices for liver transplantation are currently in use across all transplant centres in the UK. Stakeholders also highlighted a substantial body of evidence that they believe is relevant to this assessment. Additionally, it was noted that guidance outlining recommended use of these devices in routine care would be valuable to the healthcare system. Following internal discussions, the decision has been made to proceed as a routine use assessment. Information on the new HealthTech programme manual is available on the NICE website.